Toggle navigation
Home
Search
Services
Blog
Contact
About
Controlled Gene Therapy Using a Molecular Switch
Eastman, Eric M.
Valentis, Inc., Burlingame, CA, United States
Search grants from Eric Eastman
Search grants from Valentis, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Regulation of BER Gene Expression by Folate Deficiency
Signaling in pathological &physiological hypertrophy
Evaluation of H Influenzae/B-Tetanus Toxoid Vaccine
Role of Proteolysis by Canp in Platelet Activation
Travel Support to International Workshop on Sustainable Development Strategies, Impacts on Climate, New Delhi, IndiaJanuary 25-30, 1993, Award in Indian and U.S. Currencies
Recently added grants:
Institutional Career Development Core
The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve Health
Novel role of ?-arrestins in Tauopathy
Mast cells in skin innate immune defense
Differential Effects of TcdB1 and TcdB2 in C. difficile disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44NS033069-02
Application #
2037813
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (22))
Project Start
1994-06-10
Project End
1998-08-31
Budget Start
1996-09-30
Budget End
1997-08-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Valentis, Inc.
Department
Type
DUNS #
City
Burlingame
State
CA
Country
United States
Zip Code
94010
Related projects
NIH 1997
R44 NS
Controlled Gene Therapy Using a Molecular Switch
Nordstrom, Jeffrey L. / Valentis, Inc.
NIH 1996
R44 NS
Controlled Gene Therapy Using a Molecular Switch
Eastman, Eric M. / Valentis, Inc.
Comments
Be the first to comment on Eric Eastman's grant